Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S5CU
|
||||
Former ID |
DAP000595
|
||||
Drug Name |
Nisoldipine
|
||||
Synonyms |
Baymycard; Nisocor; Nisoldipin; Nisoldipino; Nisoldipinum; Sular; Syscor; Zadipina; Bay k 5552; Nisoldipino [INN-Spanish]; Nisoldipinum [INN-Latin]; Sular (TN); Bay-k-5552; Nisoldipine (JAN/USAN/INN); Nisoldipine [USAN:BAN:INN:JAN]; Isobutyl 1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl)-3-pyridincarboxylat;Methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; (+-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester; 3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antihypertensive Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H24N2O6
|
||||
InChI |
InChI=1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3
|
||||
InChIKey |
VKQFCGNPDRICFG-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 63675-72-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9901, 5054384, 6595685, 6951250, 7594280, 7847684, 7980129, 8152772, 11528722, 12012773, 14780577, 26719878, 26758055, 29223593, 46386699, 46504546, 48416330, 49681768, 53787999, 56313694, 56463094, 57322301, 80626920, 81092916, 92307945, 92308528, 92308896, 92711446, 93166842, 103219831, 103680984, 104306583, 117875317, 118048486, 121363368, 124658895, 124799896, 125355226, 126630843, 126657331, 126665640, 131322121, 131846259, 134337886, 135004762, 135650722, 135692260, 137122027, 137349418, 139157574
|
||||
SuperDrug ATC ID |
C08CA07
|
||||
SuperDrug CAS ID |
cas=063675729
|
||||
Target and Pathway | |||||
Target(s) | Calcium channel | Target Info | Blocker | [537487] | |
References | |||||
Ref 538334 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 079051. | ||||
Ref 539644 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2524). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.